kapil Bhutada

kapil Bhutada

Medicago Inc - Québec / Canada
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4983929
person_outline kapil Bhutada's MOST POPULAR ARTICLES
1-) Efficacy and safety of a recombinant plant-based adjuvanted Covid-19 vaccine New England journal of medicine 386 (22), 2084-2096, 2022
2-) Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without ComorbiditiesN Charland, P Gobeil, S Pillet, I Boulay, A Séguin, A Makarkov, G Heizer, ...npj Vaccines 7 (1), 142, 2022
3-) Interim report of a phase 2 randomized trial of a plant-produced virus-like particle vaccine for Covid-19 in healthy adults aged 18-64 and older adults aged 65 and olderP Gobeil, S Pillet, I Boulay, A Séguin, A Makarkov, G Heizer, K Bhutada, ...
4-) Phase 2 randomized trial of an AS03 adjuvanted plant-based virus-like particle vaccine for Covid-19 in healthy adults, older adults and adults with comorbiditiesP Gobeil, S Pillet, I Boulay, A Séguin, A Makarkov, G Heizer, K Bhutada, ...medRxiv, 2021.05. 14.21257248, 2021152021
5-) Efficacy and safety of a plant-based virus-like particle vaccine for COVID-19 adjuvanted with AS03KJ Hager, GP Marc, P Gobeil, RS Diaz, G Heizer, C Llapur, AI Makarkov, ...Medrxiv, 2022.01. 17.22269242, 202272022